We are live on
!
Find out more
CorMedix
CRMD
CRMD
80 hedge funds and large institutions have $59.4M invested in CorMedix in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
8% more capital invested
Capital invested by funds: $55M → $59.4M (+$4.35M)
3.25% more ownership
Funds ownership: 31% → 34.25% (+3.3%)
1% more funds holding
Funds holding: 79 → 80 (+1)
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
1% more call options, than puts
Call options by funds: $364K | Put options by funds: $361K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
26
Reduced
25
Closed
6
Calls
$364K
Puts
$361K
Net Calls
+$3K
Net Calls Change
-$354K
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$7.78M |
| 2 |
Goldman Sachs
New York
|
+$177K |
| 3 |
Barclays
London,
United Kingdom
|
+$151K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$136K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$109K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.07M |
| 2 |
Renaissance Technologies
New York
|
-$549K |
| 3 |
Two Sigma Advisers
New York
|
-$375K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$137K |
| 5 |
Two Sigma Investments
New York
|
-$121K |
